Anthony Bergmann
Director of Finance/CFO en CAPRICOR THERAPEUTICS, INC. .
Fortuna: 16 167 $ al 31/03/2024
Perfil
Anthony J.
Bergmann has held the following positions in his career: Treasurer & Finance Director at Capricor, Inc. starting in 2013, and Chief Financial Officer at Capricor Therapeutics, Inc. starting in 2018.
He completed his undergraduate degree at Providence College in 2008 and obtained an MBA from USC Marshall School of Business in 2013.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2024 | 2 381 ( 0.01% ) | 16 167 $ | 31/03/2024 |
Cargos activos de Anthony Bergmann
| Empresas | Cargo | Inicio |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Director of Finance/CFO | 01/01/2018 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Director of Finance/CFO | 01/01/2012 |
Formación de Anthony Bergmann.
| Providence College | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Bergmann
